UTILIZACION DE AGENTES ANTIFIBRINOLITICOS PARA PREPARACION DE TAMPONES, COMPRESAS Y APOSITOS

Utilización del ácido tranexámico como único principio activo para la preparación o producción de tampones, compresas o apósitos medicinales para hemostasia local rápida. Hemostatic wound treatment involves applying an antifibrinolytic agent to a substrate and then placing the substrate onto the wou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	BOETHIUS, JORGEN
Format:	Patent
Sprache:	spa
Schlagworte:	BANDAGES, DRESSINGS OR ABSORBENT PADS CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS DISINFECTION, STERILISATION, OR DEODORISATION OF AIR FILTERS IMPLANTABLE INTO BLOOD VESSELS FIRST-AID KITS FOMENTATION HUMAN NECESSITIES HYGIENE MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES MEDICAL OR VETERINARY SCIENCE METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROSTHESES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TREATMENT OR PROTECTION OF EYES OR EARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Utilización del ácido tranexámico como único principio activo para la preparación o producción de tampones, compresas o apósitos medicinales para hemostasia local rápida. Hemostatic wound treatment involves applying an antifibrinolytic agent to a substrate and then placing the substrate onto the wound. Independent claims are also included for the following: (1) a hemostatic patch comprising the substrate containing the antifibrinolytic agent for effecting hemostasis; (2) a combination of the hemostatic patch and a disposable seal-tight envelope in which the patch is sealed to be sterile and to stay moist until use; and (3) a hemostatic medical kit comprising at least one substrate and a solution of an antifibrinolytic agent for impregnating the substrate.